Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 3
2005 5
2006 8
2007 7
2008 2
2009 2
2011 3
2012 7
2013 4
2014 2
2015 3
2016 6
2017 8
2018 7
2019 6
2020 8
2021 13
2022 12
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM).
Tiseo G, Brigante G, Giacobbe DR, Maraolo AE, Gona F, Falcone M, Giannella M, Grossi P, Pea F, Rossolini GM, Sanguinetti M, Sarti M, Scarparo C, Tumbarello M, Venditti M, Viale P, Bassetti M, Luzzaro F, Menichetti F, Stefani S, Tinelli M. Tiseo G, et al. Among authors: luzzaro f. Int J Antimicrob Agents. 2022 Aug;60(2):106611. doi: 10.1016/j.ijantimicag.2022.106611. Epub 2022 Jun 11. Int J Antimicrob Agents. 2022. PMID: 35697179 Free article.
Endemic Systemic Mycoses in Italy: A Systematic Review of Literature and a Practical Update.
Zerbato V, Di Bella S, Pol R, D'Aleo F, Angheben A, Farina C, Conte M, Luzzaro F; Gianluigi Lombardi on behalf of the AMCLI Mycology Committee; Luzzati R, Principe L. Zerbato V, et al. Among authors: luzzaro f. Mycopathologia. 2023 Aug;188(4):307-334. doi: 10.1007/s11046-023-00735-z. Epub 2023 Jun 9. Mycopathologia. 2023. PMID: 37294504 Free PMC article. Review.
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey.
Di Bella S, Antonello RM, Sanson G, Maraolo AE, Giacobbe DR, Sepulcri C, Ambretti S, Aschbacher R, Bartolini L, Bernardo M, Bielli A, Busetti M, Carcione D, Camarlinghi G, Carretto E, Cassetti T, Chilleri C, De Rosa FG, Dodaro S, Gargiulo R, Greco F, Knezevich A, Intra J, Lupia T, Concialdi E, Bianco G, Luzzaro F, Mauri C, Morroni G, Mosca A, Pagani E, Parisio EM, Ucciferri C, Vismara C, Luzzati R, Principe L. Di Bella S, et al. Among authors: luzzaro f. Anaerobe. 2022 Jun;75:102583. doi: 10.1016/j.anaerobe.2022.102583. Epub 2022 May 11. Anaerobe. 2022. PMID: 35568274 Free article. Review.
Time to reconsider moxifloxacin anti-anaerobic activity?
Principe L, Sanson G, Luzzati R, Aschbacher R, Pagani E, Luzzaro F, Di Bella S. Principe L, et al. Among authors: luzzaro f. J Chemother. 2023 Jul;35(4):367-368. doi: 10.1080/1120009X.2022.2106637. Epub 2022 Aug 10. J Chemother. 2023. PMID: 35947127
Polypyridine ligands as potential metallo-β-lactamase inhibitors.
La Piana L, Viaggi V, Principe L, Di Bella S, Luzzaro F, Viale M, Bertola N, Vecchio G. La Piana L, et al. Among authors: luzzaro f. J Inorg Biochem. 2021 Feb;215:111315. doi: 10.1016/j.jinorgbio.2020.111315. Epub 2020 Nov 21. J Inorg Biochem. 2021. PMID: 33285370
CTX-M: changing the face of ESBLs in Europe.
Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N. Livermore DM, et al. Among authors: luzzaro f. J Antimicrob Chemother. 2007 Feb;59(2):165-74. doi: 10.1093/jac/dkl483. Epub 2006 Dec 6. J Antimicrob Chemother. 2007. PMID: 17158117 Review.
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
Di Pilato V, Principe L, Andriani L, Aiezza N, Coppi M, Ricci S, Giani T, Luzzaro F, Rossolini GM. Di Pilato V, et al. Among authors: luzzaro f. Clin Microbiol Infect. 2023 Apr;29(4):537.e1-537.e8. doi: 10.1016/j.cmi.2022.11.011. Epub 2022 Nov 19. Clin Microbiol Infect. 2023. PMID: 36414199
106 results